infants
New ACIP Panel Votes to Recommend Clesrovimab, Second Antibody to Prevent RSV in Infants
The seven newly appointed members of ACIP voted 5-to-2 to recommend Enflonsia, the second long-acting monoclonal ...
JUNE 26, 2025
FDA Approves Enflonsia, Second RSV Antibody for Infants
The FDA has approved the second monoclonal antibody for the prevention of RSV in neonates and infants, ...
JUNE 10, 2025
FDA Raises the Red Flag About Probiotics in Infants
The FDA recently raised concerns about the use of probiotics in hospitalized preterm infants.
DECEMBER 27, 2023
ACIP Recommends PREVNAR 20 for Infants and Children
The CDC’s ACIP recently voted to recommend the 20-valent Pneumococcal Conjugate Vaccine for routine use to ...
JULY 19, 2023
Beyfortus Approved to Prevent RSV in Infants and Children
The FDA approved Beyfortus (Sanofi and AstraZeneca) for the prevention of RSV lower respiratory tract disease in ...
JULY 18, 2023
FDA Advisory Committee Supports Nirsevimab to Prevent RSV in Infants
The FDA Antimicrobial Drugs Advisory Committee endorsed the safety and efficacy of an experimental ...
JUNE 9, 2023
High Drug Concentrations Lead to Voluntary Recall of Infants’ Ibuprofen
Tris Pharma Inc. voluntarily recalled three lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP 50 ...
JANUARY 31, 2019
FDA Approves Fluzone Quadrivalent for Infants and Toddlers
The FDA expanded the use of the 0.5 mL vaccine for children from 6 to 35 months of age.
JANUARY 23, 2019
